Troluce Capital Advisors LLC

Position in ASND — Ascendis Pharma A/S

CIK 1910321 DORADO, PR

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$22,781,508

+$16,817,208 QoQ

Shares Held

99,600

+232.0% QoQ

Ownership

0.152%

of shares outstanding

% of Portfolio

2.91%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Troluce Capital Advisors LLC holds $78,166,662 across 5 Biotechnology names. ASND ranks #1 (29.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S This page	99,600	$22,781,508
2	STOK	Stoke Therapeutics, Inc.	652,800	$21,255,168
3	MLYS	Mineralys Therapeutics, Inc.	655,000	$17,743,950
4	GHRS	GH Research PLC	990,472	$13,926,036
5	IMTX	Immatics N.V.	250,000	$2,460,000

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,781,508	99,600	+232.0%	Shares	Sole	2026-05-15
2025-09-30	$5,964,300	30,000	0.0%	Shares	Sole	2025-11-14
2025-06-30	$5,178,000	30,000	—	Shares	Sole	2025-08-14
No filing history on record for this holder in this stock.